ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Puerarin specifically disrupts osteoclast activation via blocking integrin-β3 Pyk2/Src/Cbl signaling pathway

Qiu, Zuocheng; Li, Ling; Huang, Yuying; Shi, Keda; Zhang, Lizhong; Huang, Cuishan; Liang, Jiechao; Zeng, Qingqiang; Wang, Jiali; He, Xiangjiu; Qin, Ling; Wang, Xinluan*广东药学院; 中山大学; 中国科学院
Journal of Orthopaedic Translation2022-3DOI: 10.1016/j.jot.2022.01.003
18被引11阅读
引用收藏
分享

摘要

Objective: Given the limitations of current anti-resorption agents for postmenopausal osteoporosis, there is a need for alternatives without impairing coupling crosstalk between bone resorption and bone formation ie. osteo-clastogenesis. Puerarin, a unique C-glycoside isoflavonoid, was found to be able to prevent bone loss by inhibiting bone resorption, but the underlying mechanism was controversial. In this study, we investigated the effects of puerarin on osteoclastic differentiation, activation and bone resorption and its underlying molecular mechanism in vitro, and then evaluated the effects of puerarin on bone metabolism using an ovariectomized (OVX) rat model.Methods: In vitro, the effect of puerarin on osteoclastic cytotoxicity, differentiation, apoptosis, activation and function were studied in raw 264.7 cells and mouse BMMs. Mechanistically, osteoclast-related makers were determined by RT-PCR, western blot, immunofluorescence, and kinase activity assay. In vivo, Micro-CT, histology, serum bone biomarker, and mechanical testing were used to evaluate the effects of puerarin on preventing osteoporosis.Results: Puerarin significantly inhibited osteoclast activation and bone resorption, without affecting osteoclasto-genesis or apoptosis. In terms of mechanism, the expressions of protein of integrin-133 and phosphorylations of Src, Pyk2 and Cbl were lower in puerarin group than those in the control group. Oral administration of puerarin prevented OVX-induced trabecular bone loss and significantly improved bone strength in rats. Moreover, puerarin significantly decreased trap positive osteoclast numbers and serum TRAP-5b, CTx1, without affecting bone for-mation rate.Conclusions: Collectively, puerarin prevented the bone loss in OVX rat through suppression of osteoclast activation and bone resorption, by inhibiting integrin-133-Pyk2/Cbl/Src signaling pathway, without affecting osteoclasts formation or apoptosis.Translational potential of this article: These results demonstrate the unique mechanism of puerarin on bone metabolism and provide a novel agent for prevention of postmenopausal osteoporosis.

学科与关键词

关键词
PuerarinF-actin ringIntegrin-?? 3Pyk2CblSrcOsteoclast activation
相关
加载中…
  • A novel RANKL-targeted flavonoid glycoside prevents osteoporosis through inhibiting NFATc1 and reactive oxygen species
    Hong, Guoju; Chen, Zhenqiu; Han, Xiaorui; Zhou, Lin; Pang, Fengxiang; Wu, Rishana; Shen, Yingshan; He, Xiaoming; Hong, Zhinan; Li, Ziqi; He, Wei; Wei, Qiushi*Clinical and Translational Medicine, 2021, 11(5): e392.被引 31
  • A Novel RANKL-Targeted Furoquinoline Alkaloid Ameliorates Bone Loss in Ovariectomized Osteoporosis through Inhibiting the NF-κB Signal Pathway and Reducing Reactive Oxygen Species
    Wong, Puiian; Lv, Zheng; Li, Jinglan; Wei, Qiushi; Xu, LiangLiang*; Fang, Bin*; Luo, Yiwen*; He, Mincong*Oxidative Medicine and Cellular Longevity, 2022, 2022: 5982014.被引 6
  • Quercetin-6-C-β-d-glucopyranoside isolated from Ulmus wallichiana planchon is more potent than quercetin in inhibiting osteoclastogenesis and mitigating ovariectomy-induced bone loss in rats
    Siddiqui J A; Sharan K; Swarnkar G; Rawat P; Kumar M; Manickavasagam L; Maurya R; Pierroz D; Chattopadhyay N*MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2011, 18(2): 198-207.
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Orthopaedic Translation
发表日期
2022-03
卷期
第 33 卷
页码
55-69
DOI
10.1016/j.jot.2022.01.003
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81773964, 81903618]; Guangdong Basic and Applied Basic Research Foundation [2021B1515120061]; Guangzhou Basic and Applied Basic Research Foundation [202102021160]; Shenzhen Inter-national Collaborative Project [GJHZ20190821160803823]; Guangdong Provincial Key Laboratory of Traditional Chinese Medicine Informatiza-tion [2021B1212040007]

作者

  • Q

    Qiu, Zuocheng (第一作者)

    chinese acad sci

  • L

    Li, Ling

    chinese acad sci

查看全部 12 位作者收起作者
  • H

    Huang, Yuying

    guangdong pharmaceut univ

  • S

    Shi, Keda

    chinese acad sci

  • Z

    Zhang, Lizhong

    chinese acad sci

  • H

    Huang, Cuishan

    chinese acad sci

  • L

    Liang, Jiechao

    chinese acad sci

  • Z

    Zeng, Qingqiang

    chinese acad sci

  • W

    Wang, Jiali

    sun yat sen univ

  • H

    He, Xiangjiu

    guangdong pharmaceut univ

  • Q

    Qin, Ling

    chinese acad sci · chinese univ hong kong

  • W

    Wang, Xinluan (通讯)

    chinese univ hong kong · chinese acad sci

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417